Atlas Trials

Longitudinal Immune-phenotyping of HCC Following MK-3475

Clinical trial NCT04224480 · UNKNOWN

Trial details

NCT number
NCT04224480
Sponsor
National Cancer Centre, Singapore
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2019-12-10
Primary completion
2025-12-31
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.